Global Pharmaceuticals & Biotech Most Popular Stocks

Zota Health Care

Market Cap: ₹42.6b

Develops, manufactures, and markets pharmaceutical products in India and internationally.

Xinjiang Bai Hua Cun Pharma TechLtd

Market Cap: CN¥3.4b

Engages in the pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.

Solid Biosciences

Market Cap: US$478.9m

Develops therapies for neuromuscular and cardiac diseases in the United States.

CytomX Therapeutics

Market Cap: US$478.2m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

Fulcrum Therapeutics

Market Cap: US$478.2m

A clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States.

Vireo Growth

Market Cap: CA$664.9m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Orum Therapeutics

Market Cap: ₩670.0b

A biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases.

Emergent BioSolutions

Market Cap: US$475.4m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

Inhibrx Biosciences

Market Cap: US$473.4m

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

Monopar Therapeutics

Market Cap: US$472.8m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

Zhejiang Wecome Pharmaceutical

Market Cap: CN¥3.4b

Engages in the research and development, production, and sale of modern traditional Chinese and western medicine in China.

Alar Pharmaceuticals

Market Cap: NT$14.3b

A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.

Jiangsu Recbio Technology

Market Cap: HK$3.6b

A vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People’s Republic of China.

Monte Rosa Therapeutics

Market Cap: US$462.6m

A clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.

Cryoport

Market Cap: US$460.6m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

Shanghai Shenqi Pharmaceutical Investment Management

Market Cap: CN¥3.3b

Operates as a pharmaceutical manufacturing holding investment company in China.

Formycon

Market Cap: €390.4m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

Renata

Market Cap: ৳55.6b

Manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh.

Ocugen

Market Cap: US$456.0m

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.

Blau Farmacêutica

Market Cap: R$2.4b

A pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.

Guangdong VTR Bio-Tech

Market Cap: CN¥3.2b

Researches, develops, produces, sells, and services biological enzyme preparations, biosynthetics, and nutrition and health products in China.

Cresco Labs

Market Cap: CA$632.1m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

Zhejiang Shengda Bio-Pharm

Market Cap: CN¥3.2b

Develops, produces, and sells food and feed additives for pharmaceutical, nutritional, food, and animal feed industry.

Honz Pharmaceutical

Market Cap: CN¥3.2b

Engages in the research and development, manufacturing, and sales of pediatric medicines in China.

Hunan Hansen Pharmaceutical

Market Cap: CN¥3.2b

Produces and sells traditional Chinese preparations in China and internationally.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥67.2b

Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.

Enwei Pharmaceutical

Market Cap: CN¥3.2b

Develops and sells Chinese medicines in China.

Beximco Pharmaceuticals

Market Cap: ৳54.4b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

Guizhou Yibai Pharmaceutical

Market Cap: CN¥3.2b

Researches, develops, produces, and sells pharmaceutical products in China.

Shanghai Kehua Bio-EngineeringLtd

Market Cap: CN¥3.2b

Researches and develops, produces, and sells in vitro diagnostic reagents, medical testing equipment and other products in China and internationally.

Tibet Duo Rui Pharmaceutical

Market Cap: CN¥3.2b

Engages in the research and development, production, and sale of chemical pharmaceutical preparations and its raw materials in China.

XOMA Royalty

Market Cap: US$443.4m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

Abbott Laboratories (Pakistan)

Market Cap: PK₨124.5b

Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.

Guangdong Jiaying Pharmaceutical

Market Cap: CN¥3.1b

Guangdong Jiaying Pharmaceutical Co., Ltd.

RAPT Therapeutics

Market Cap: US$436.3m

Operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States.

Larimar Therapeutics

Market Cap: US$436.1m

A clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.